摘要 |
<p>The invention relates to compounds of the formulaand to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<17>, R<f>, A, X, and Y are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formulas 1, methods of using the compounds of formula 1 in the treatment of infections and methods of preparing the compounds of formula 1.</p> |